All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

SPECT Imaging Shows Promise for Detecting CTE-Related Brain Changes, Says Amen Clinics

By

Amen Clinics

5d ago· 11 min readen

Summary

This article from Amen Clinics discusses how SPECT (Single Photon Emission Computed Tomography) imaging can detect brain changes associated with Chronic Traumatic Encephalopathy (CTE), a progressive brain disease caused by repeated head injuries. The piece explains the pathology of CTE, including tau protein buildup and brain cell death, and argues that SPECT scans offer a valuable tool for identifying CTE-related abnormalities in living patients. It emphasizes that cognitive decline is not inevitable and promotes brain health protection strategies, while also serving as promotional content for Amen Clinics' diagnostic services.

Source

Twitter / XSPECT Imaging Shows Promise for Detecting CTE-Related Brain Changes, Says Amen Clinicsamenclinics.com

Key quotes

· 3 pulled
Chronic Traumatic Encephalopathy is a progressive brain disease caused by repeated head injuries or repeated blows to the head.
Over time, these repeated head injuries damage brain cells and disrupt healthy brain function.
Some people think that age-related brain changes are an inevitable part of life. But cognitive decline does not need to be part of anyone's story.
Snippet from the RSS feed
Facebook-f X-twitter Youtube Table of Contents Can SPECT Scans Identify CTE-Related Brain Changes? Some people think that age-related brain changes are an inevitable part of life. But cognitive decline does not need to be part of anyone’s story. There are

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.